BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23748830)

  • 41. Nasopharyngeal adenoid cystic carcinoma: a rare nasopharyngeal tumor.
    Papadas T; Chorianopoulos D; Mastronikolis N
    Eur Rev Med Pharmacol Sci; 2007; 11(1):55-7. PubMed ID: 17405348
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Therapeutic options in sinunasal adenoid cystic carcinomas--a case report and review].
    Mozet C; Stumpp P; Mekonnen B; Dietz A
    Laryngorhinootologie; 2009 Oct; 88(10):631-8. PubMed ID: 19813159
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment outcomes after reduction of the target volume of intensity-modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective, multi-center, randomized clinical trial.
    Yang H; Chen X; Lin S; Rong J; Yang M; Wen Q; Shang C; He L; Ren P; Xu S; Zhang J; Liu Q; Pang H; Shi X; Fan J; Sun X; Ma D; Tan B; Zhang T; Zhang L; Hu D; Du X; Zhang Y; Wen S; Zhang X; Wu J
    Radiother Oncol; 2018 Jan; 126(1):37-42. PubMed ID: 28864073
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adding concurrent chemotherapy to postoperative radiotherapy improves locoregional control but Not overall survival in patients with salivary gland adenoid cystic carcinoma-a propensity score matched study.
    Hsieh CE; Lin CY; Lee LY; Yang LY; Wang CC; Wang HM; Chang JT; Fan KH; Liao CT; Yen TC; Fang KH; Tsang YM
    Radiat Oncol; 2016 Mar; 11():47. PubMed ID: 27000157
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of clinical outcomes of patients with adenoid cystic carcinoma of Bartholin glands.
    Yoon G; Kim HS; Lee YY; Kim TJ; Choi CH; Song SY; Kim BG; Bae DS; Lee JW
    Int J Clin Exp Pathol; 2015; 8(5):5688-94. PubMed ID: 26191282
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the treatment of incompletely and completely resected adenoid cystic carcinomas of the head and neck: initial clinical results and toxicity of treatment.
    Münter MW; Schulz-Ertner D; Hof H; Nikoghosyan A; Jensen A; Nill S; Huber P; Debus J
    Radiat Oncol; 2006 Jun; 1():17. PubMed ID: 16756669
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Failure patterns and survival in patients with nasopharyngeal carcinoma treated with intensity modulated radiation in Northwest China: a pilot study.
    Wang J; Shi M; Hsia Y; Luo S; Zhao L; Xu M; Xiao F; Fu X; Li J; Zhou B; Long X
    Radiat Oncol; 2012 Jan; 7():2. PubMed ID: 22233756
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adenoid cystic carcinoma of the head and neck: Patterns of recurrence and implications for intensity-modulated radiotherapy.
    Gao RW; Routman DM; Harmsen WS; Ebrahimi S; Foote RL; Ma DJ; Neben-Wittich M; McGee LA; Patel SH; Moore EJ; Choby GW; Tasche KK; Price KA; Gamez ME; Lester SC
    Head Neck; 2023 Jan; 45(1):187-196. PubMed ID: 36222355
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
    Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C
    Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
    Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy.
    Hua YJ; Han F; Lu LX; Mai HQ; Guo X; Hong MH; Lu TX; Zhao C
    Eur J Cancer; 2012 Dec; 48(18):3422-8. PubMed ID: 22835782
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Thoracic adenoid cystic carcinomas].
    Le Péchoux C; Baldeyrou P; Ferreira I; Mahé M
    Cancer Radiother; 2005 Nov; 9(6-7):358-61. PubMed ID: 16168695
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Adenoid cystic carcinoma].
    Alfaro-Rubio A; Sanmartín Jiménez O; Serra-Guillén C; Requena Caballero C; Hueso Gabriel L; Botella-Estrada R; Nagore Enguídanos E; Llombart Cussac B; Guillén Barona C
    Actas Dermosifiliogr; 2006 Nov; 97(9):578-80. PubMed ID: 17173761
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of adenoid cystic carcinoma of minor salivary glands.
    Triantafillidou K; Dimitrakopoulos J; Iordanidis F; Koufogiannis D
    J Oral Maxillofac Surg; 2006 Jul; 64(7):1114-20. PubMed ID: 16781345
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A phase II study of adaptive two-step intensity-modulated radiation therapy (IMRT) with chemotherapy for loco-regionally advanced nasopharyngeal cancer (JCOG1015).
    Nishimura Y; Ishikura S; Shibata T; Kodaira T; Ito Y; Tsuchiya K; Murakami Y; Saitoh JI; Akimoto T; Nakata K; Yoshimura M; Teshima T; Toshiyasu T; Ota Y; Ishikawa K; Shimizu H; Minemura T; Nakamura K; Hiraoka M
    Int J Clin Oncol; 2020 Jul; 25(7):1250-1259. PubMed ID: 32221802
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adenoid cystic carcinoma of the sinonasal tract: treatment results.
    Rhee CS; Won TB; Lee CH; Min YG; Sung MW; Kim KH; Shim WS; Kim YM; Kim JW
    Laryngoscope; 2006 Jun; 116(6):982-6. PubMed ID: 16735899
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy-the national cancer centre singapore experience.
    Tham IW; Hee SW; Yeo RM; Salleh PB; Lee J; Tan TW; Fong KW; Chua ET; Wee JT
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1481-6. PubMed ID: 19386431
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term outcomes of patients in different histological subtypes of primary nasopharyngeal adenocarcinoma: A single-center experience with 71 cases.
    Sun M; Qu Y; Wang K; Wu R; Zhang Y; Zhang S; Xiao J; Yi J; Gao L; Xu G; Huang X; Luo J
    Oral Oncol; 2020 Dec; 111():104923. PubMed ID: 32795912
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Phase 1/2 ACCEPT Trial: Concurrent Cetuximab and Intensity Modulated Radiation Therapy with Carbon Ion Boost for Adenoid Cystic Carcinoma of the Head and Neck.
    Adeberg S; Akbaba S; Lang K; Held T; Verma V; Nikoghosyan A; Bernhardt D; Münter M; Freier K; Plinkert P; Hauswald H; Herfarth K; Rieken S; Debus J; Jensen AD
    Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):167-173. PubMed ID: 31586664
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of concurrent chemotherapy to intensity-modulated radiotherapy (IMRT) after neoadjuvant docetaxel and cisplatin treatment in locoregionally advanced nasopharyngeal carcinoma.
    Zhang L; Shan GP; Li P; Cheng PJ
    Med Oncol; 2015 Mar; 32(3):41. PubMed ID: 25631634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.